TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
Jérémy Béguin, et al. Molecular Therapy Oncolytics, September 2020 – Read the article Publication